loadpatents
Patent applications and USPTO patent grants for Betschart; Claudia.The latest application filed is for "diaza-spiro[5.5]undecanes useful as orexin receptor antagonists".
Patent | Date |
---|---|
Disubstituted heteroaryl-fused pyridines Grant 8,742,106 - Badiger , et al. June 3, 2 | 2014-06-03 |
Diaza-spiro[5.5]undecanes Useful As Orexin Receptor Antagonists App 20130281463 - Badiger; Sangamesh ;   et al. | 2013-10-24 |
Diaza-spiro[5.5]undecanes Grant 8,530,648 - Badiger , et al. September 10, 2 | 2013-09-10 |
Diaza-spiro[5.5]undecanes App 20120264748 - Badiger; Sangamesh ;   et al. | 2012-10-18 |
Disubstituted Heteroaryl-fused Pyridines App 20120258973 - Babiger; Sangamesh ;   et al. | 2012-10-11 |
Di/tri-aza-spiro-C9-C11alkanes App 20120165331 - BADIGER; Sangamesh ;   et al. | 2012-06-28 |
Diaza-spiro[5.5]undecanes App 20120101110 - BADIGER; Sangamesh ;   et al. | 2012-04-26 |
Macrocyclic compounds useful as BACE inhibitors Grant 8,039,455 - Betschart , et al. October 18, 2 | 2011-10-18 |
Heteroaryl nitrile derivatives Grant 7,820,818 - Altmann , et al. October 26, 2 | 2010-10-26 |
4-aryl-butane-1,3-diamides App 20100222396 - BEHNKE; Dirk ;   et al. | 2010-09-02 |
Macrocyclic Lactams and Pharmaceutical Use Thereof App 20100022500 - AUBERSON; Yves ;   et al. | 2010-01-28 |
Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof Grant 7,612,054 - Auberson , et al. November 3, 2 | 2009-11-03 |
Macrocyclic lactams and pharmaceutical use thereof Grant 7,612,055 - Auberson , et al. November 3, 2 | 2009-11-03 |
Heteroaryl Nitrile Derivatives App 20090227596 - Altmann; Eva ;   et al. | 2009-09-10 |
Hetereoaryl nitrile derivatives Grant 7,544,688 - Altmann , et al. June 9, 2 | 2009-06-09 |
Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases App 20090054467 - Betschart; Claudia ;   et al. | 2009-02-26 |
Macrocyclic Compounds Useful As Base Inhibitors App 20090029960 - Betschart; Claudia ;   et al. | 2009-01-29 |
Pyrrolo pyrimidines as agents for the inhibition of cystein proteases Grant 7,452,886 - Betschart , et al. November 18, 2 | 2008-11-18 |
Macrocyclic Compounds Useful as Bace Inhibitors App 20080132477 - Betschart; Claudia ;   et al. | 2008-06-05 |
Macrocyclic Compounds Having Aspartic Protease Inhibiting Activity And Pharmaceutical Uses Thereof App 20080070885 - Betschart; Claudia ;   et al. | 2008-03-20 |
Dipeptide Nitriles App 20080027060 - Altmann; Eva ;   et al. | 2008-01-31 |
Novel dibenzo [b, f] oxepine-10-carboxamides and pharmaceutical uses thereof App 20070111991 - Auberson; Yves ;   et al. | 2007-05-17 |
Macrocyclic lactams and pharmaceutical use thereof App 20070072792 - Auberson; Yves ;   et al. | 2007-03-29 |
Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof App 20060223745 - Betschart; Claudia ;   et al. | 2006-10-05 |
Hetereoaryl nitrile derivatives App 20060142575 - Altmann; Eva ;   et al. | 2006-06-29 |
Pyrrolo pyrimidines as agents for the inhibition of cystein proteases App 20050054851 - Betschart, Claudia ;   et al. | 2005-03-10 |
Dipeptide derivatives App 20040110806 - Altmann, Eva ;   et al. | 2004-06-10 |
Dipeptide nitriles App 20040029814 - Altmann, Eva ;   et al. | 2004-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.